The effect of granulocyte‐macrophage colony‐stimulating factor on myeloid cells and its clinical applications

Granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) is a naturally occurring growth factor produced by several cell types in response to a variety of stimuli. GM‐CSF has potent stimulatory effects on the growth and maturation of hematopoietic cells and has profound effects on mature circulating effector cells. Clinical applications of GM‐CSF include ameliorating chemotherapy‐induced neutropenia and enhancing hematopoietic recovery after bone marrow transplantation. This review evaluates the effect of GM‐CSF on myeloid cells and its clinical applications.

[1]  J. Nemunaitis.  Use of hematopoietic growth factors in marrow transplantation. , 1994, Current opinion in oncology.

[2]  E. Jaffee,et al.  Controlled release, biodegradable cytokine depots: a new approach in cancer vaccine design. , 1993, Cancer research.

[3]  E. Jaffee,et al.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. M. Roberts.  A signal chain of events , 1992, Nature.

[5]  S. Grant,et al.  Bryostatin 1 modulates the proliferation and lineage commitment of human myeloid progenitor cells exposed to recombinant interleukin-3 and recombinant granulocyte-macrophage colony-stimulating factor. , 1992, Blood.

[6]  M. Hallek,et al.  Granulocyte‐Macrophage colony‐stimulating factor and steel factor induce phosphorylation of both unique and overlapping signal transduction intermediates in a human factor‐dependent hematopoietic cell line , 1992, Journal of cellular physiology.

[7]  K. Umezawa,et al.  Granulocyte-macrophage colony-stimulating factor primes phospholipase D activity in human neutrophils in vitro: role of calcium, G-proteins and tyrosine kinases. , 1992, Cellular signalling.

[8]  D. Quelle,et al.  Interleukin 3, granulocyte-macrophage colony-stimulating factor, and transfected erythropoietin receptors mediate tyrosine phosphorylation of a common cytosolic protein (pp100) in FDC-ER cells. , 1992, The Journal of biological chemistry.

[9]  T. Kaneko,et al.  Stimulation of phosphoinositol turnover and protein kinase C activation by granulocyte-macrophage colony-stimulating factor in HL-60 cells. , 1992, Blood.

[10]  J. Gomez-Cambronero,et al.  Granulocyte-macrophage colony-stimulating factor-induced protein tyrosine phosphorylation of microtubule-associated protein kinase in human neutrophils. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  C. Punt.  Regulation of hematopoietic cell function by protein tyrosine kinase-encoding oncogenes, a review. , 1992, Leukemia research.

[12]  P. Morrissey,et al.  Cloning of the low-affinity murine granulocyte-macrophage colony-stimulating factor receptor and reconstitution of a high-affinity receptor complex. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Le,et al.  Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related. , 1992, Oncogene.

[14]  J. Howard Scarffe.  Emerging clinical uses for GM-CSF. , 1991, European journal of cancer.

[15]  N. Yamaguchi,et al.  Identification of the second subunit of the murine interleukin‐5 receptor: interleukin‐3 receptor‐like protein, AIC2B is a component of the high affinity interleukin‐5 receptor. , 1991, The EMBO journal.

[16]  C. McInnes,et al.  Cloning and expression of a cDNA encoding ovine granulocyte-macrophage colony-stimulating factor. , 1991, Gene.

[17]  W. Hiddemann,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse. , 1991, Blood.

[18]  J. Metcalf,et al.  A Phase I/II Trial of Zidovudine, Interferon-α, and Granulocyte-Macrophage Colony-Stimulating Factor in the Treatment of Human Immunodeficiency Virus Type 1 Infection , 1991 .

[19]  J. Armitage,et al.  Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. , 1991, The New England journal of medicine.

[20]  J. Nemunaitis,et al.  Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation. , 1991, Blood.

[21]  M. Nakafuku,et al.  Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Tiley,et al.  Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trial , 1990, The Lancet.

[23]  P. Wakefield,et al.  Colony-stimulating factors. , 1990, Journal of the American Academy of Dermatology.

[24]  B. Barlogie,et al.  High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma. , 1990, Blood.

[25]  K. Welte,et al.  Differential effect of GM-CSF and G-CSF in cyclic neutropenia , 1990, The Lancet.

[26]  M. Engelhard,et al.  Mitoxantrone/high‐dose ara‐c and recombinant human gm‐csf in the treatment of refractory non‐hodgkin's lymphoma a pilot study , 1990, Cancer.

[27]  S. Broder,et al.  Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. , 1990, Blood.

[28]  K. Arai,et al.  Cloning and expression of a gene encoding an interleukin 3 receptor-like protein: identification of another member of the cytokine receptor gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  F. Herrmann,et al.  Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy. , 1990, The American journal of medicine.

[30]  E. Estey,et al.  Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor. , 1990, Blood.

[31]  G. Bonadonna,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  J. Radford,et al.  Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer. , 1990, British Journal of Cancer.

[33]  C. Logothetis,et al.  Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factor. , 1990, Journal of the National Cancer Institute.

[34]  S. Hammer,et al.  Effect of zidovudine and granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus replication in alveolar macrophages. , 1990, Blood.

[35]  K. Welte,et al.  Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. , 1990, Blood.

[36]  A. Burgess,et al.  Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration. , 1990, Cancer research.

[37]  J. Cebon,et al.  Characterization of the clinical effects after the first dose of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor. , 1989, Blood.

[38]  H. Gerhartz,et al.  Low-dose Ara-C plus granulocyte/macrophage colony-stimulating factor for the treatment of myelodysplastic syndromes. EORTC Leukemia Group. , 1989, Bone marrow transplantation.

[39]  A. Pileri,et al.  GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION , 1989, The Lancet.

[40]  R. Storb,et al.  Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor. , 1989, Experimental hematology.

[41]  R. Shadduck,et al.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in patients with refractory metastatic carcinoma. , 1989, Blood.

[42]  D. Linch,et al.  Granulocyte macrophage colony stimulating factor induced changes in cellular adhesion molecule expression and adhesion to endothelium: in‐vitro and in‐vivo studies in man , 1989, British journal of haematology.

[43]  D. S. Webb,et al.  Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido- 2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine , 1989, The Journal of experimental medicine.

[44]  R. Shadduck,et al.  The effect of recombinant human granulocyte macrophage colony-stimulating factor on neutrophil activation in patients with refractory carcinoma. , 1989, Blood.

[45]  T. Whiteside,et al.  Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients. , 1989, Blood.

[46]  B. Bostrom,et al.  In vivo administration of recombinant human granulocyte/macrophage colony-stimulating factor in acute lymphoblastic leukemia patients receiving purged autografts. , 1989, Blood.

[47]  F. Herrmann,et al.  Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  D. Crowther,et al.  Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study. , 1989, British Journal of Cancer.

[49]  J. Gutterman,et al.  Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor. , 1988, The New England journal of medicine.

[50]  A. Reske-Kunz,et al.  Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function. , 1988, Journal of immunology.

[51]  K. Akagawa,et al.  Effects of granulocyte-macrophage colony-stimulating factor and colony-stimulating factor-1 on the proliferation and differentiation of murine alveolar macrophages. , 1988, Journal of immunology.

[52]  R. Coleman,et al.  Neutrophil migration is defective during recombinant human granulocyte- macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans , 1988 .

[53]  M. Socinski,et al.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. , 1988, The New England journal of medicine.

[54]  D. Cerretti,et al.  Bovine GM-CSF: molecular cloning and biological activity of the recombinant protein. , 1988, Molecular immunology.

[55]  P. Hart,et al.  Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and IFN-gamma. Increased TNF-alpha but not IL-1 activity. , 1988, Journal of immunology.

[56]  J. Singer,et al.  Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. , 1988, Blood.

[57]  M. Socinski,et al.  Granulocyte-macrophage colony-stimulating factor induces the expression of the CD11b surface adhesion molecule on human granulocytes in vivo. , 1988, Blood.

[58]  D. Rosenthal,et al.  Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. , 1988, Blood.

[59]  D. Santoli,et al.  Amplification of IL-2-driven T cell proliferation by recombinant human IL-3 and granulocyte-macrophage colony-stimulating factor. , 1988, Journal of immunology.

[60]  M. Vadas,et al.  Recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) regulates f Met-Leu-Phe receptors on human neutrophils. , 1988, Immunology.

[61]  R. Bast,et al.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. , 1988, The New England journal of medicine.

[62]  D. Golde,et al.  Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. P. Fletcher,et al.  Enhancement of neutrophil function by granulocyte-macrophage colony-stimulating factor involves recruitment of a less responsive subpopulation. , 1988, Blood.

[64]  F. Herrmann,et al.  Granulocyte/macrophage colony-stimulating factor induces interleukin 1 production by human polymorphonuclear neutrophils. , 1988, Journal of immunology.

[65]  J. Griffin,et al.  Effects of recombinant human granulocyte and macrophage colony-stimulating factors on signal transduction pathways in human granulocytes. , 1987, Journal of immunology.

[66]  J. Groopman,et al.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. , 1987, The New England journal of medicine.

[67]  P. Morrissey,et al.  Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. , 1987, Journal of immunology.

[68]  E. Liehl,et al.  Recombinant human GM-CSF induces leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates. , 1987, Blood.

[69]  E. Vellenga,et al.  The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia. , 1987, Blood.

[70]  D. Williams,et al.  Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice. , 1987, The Journal of clinical investigation.

[71]  P. Allavena,et al.  Chemotactic activity of human recombinant granulocyte-macrophage colony-stimulating factor. , 1987, Immunology.

[72]  D. Metcalf.  The Role of the Colony‐Stimulating Factors in Resistance to Acute Infections , 1987, Immunology and cell biology.

[73]  D. Golde,et al.  Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. , 1986, Journal of immunology.

[74]  D. Golde,et al.  Granulocyte-macrophage colony-stimulating factor enhances phagocytosis of bacteria by human neutrophils. , 1986, Blood.

[75]  D. Friend,et al.  Characterization of the cell surface receptor for human granulocyte/macrophage colony-stimulating factor , 1986, The Journal of experimental medicine.

[76]  D. Metcalf.  The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. , 1986, Blood.

[77]  K. Arai,et al.  Isolation of cDNA for a human granulocyte-macrophage colony-stimulating factor by functional expression in mammalian cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[78]  E. Brown,et al.  Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. , 1985, Science.

[79]  D. Golde,et al.  Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils. , 1984, Science.

[80]  R. Storb,et al.  Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis. , 1982 .

[81]  A. Burgess,et al.  Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages. , 1979, Journal of immunology.

[82]  A. Burgess,et al.  Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. , 1977, The Journal of biological chemistry.

[83]  L. Sachs,et al.  The induction of clones of normal mast cells by a substance from conditioned medium. , 1966, Experimental cell research.

[84]  D. Metcalf,et al.  The growth of mouse bone marrow cells in vitro. , 1966, The Australian journal of experimental biology and medical science.

[85]  R. Dorr.  Clinical properties of yeast-derived versus Escherichia coli-derived granulocyte-macrophage colony-stimulating factor. , 1993, Clinical therapeutics.

[86]  M. Hansson,et al.  The colony stimulating factors , 1993, Medical oncology and tumor pharmacotherapy.

[87]  Dorr Rt.  Clinical properties of yeast-derived versus Escherichia coli-derived granulocyte-macrophage colony-stimulating factor , 1993 .

[88]  T. M. Roberts.  Cell biology. A signal chain of events. , 1992, Nature.

[89]  E. Vellenga,et al.  A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma. , 1991, Cancer research.

[90]  W. Fiers,et al.  Response of murine cell lines to an IL-1/IL-2-induced factor in a rat/mouse T hybridoma (PC60): differential induction of cytokines by human IL-1 alpha and IL-1 beta and partial amino acid sequence of rat GM-CSF. , 1990, Lymphokine research.

[91]  K. Miyazono,et al.  Characterization and molecular features of the cell surface receptor for human granulocyte-macrophage colony-stimulating factor. , 1990, Leukemia.

[92]  D. Linch,et al.  GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease. , 1989, Bone marrow transplantation.

[93]  S. Nimer,et al.  Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factor. , 1989, Blood.

[94]  K. Oshimi,et al.  Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia. , 1989, Experimental hematology.

[95]  A. Gratwohl,et al.  Failure of recombinant human granulocyte-macrophage colony-stimulating factor therapy in aplastic anemia patients with very severe neutropenia. , 1988, Blood.

[96]  S. Clark.  Biological activities of human granulocyte-macrophage colony-stimulating factor. , 1988, International journal of cell cloning.

[97]  C. Begley,et al.  Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. , 1987, Experimental hematology.

[98]  D. Golde,et al.  Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. , 1987, Blood.

[99]  V. Price,et al.  Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. , 1986, Science.

[100]  P. Sehgal,et al.  Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF , 1986, Nature.

[101]  L. Hood,et al.  Purification and partial amino acid sequence of asialo murine granulocyte-macrophage colony stimulating factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[102]  D. Golde,et al.  Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator , 1985, Nature.

[103]  A. Kelso,et al.  Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte—macrophage colony stimulating factor , 1984, Nature.